Health

The Pharmaceutical Research & Manufacturers Association (PhRMA) has hired Edelman Public Relations Worldwide to help position the pharmaceutical industry as a "leading source of information to the public" on the issue of bioterrorism. For the other side of the story, check out what Corpwatch.org has to say about wartime profiteering by drug companies and the controversy on patented drugs which started when the first signs of anthrax attacks appeared in the US.

Public health scientists Samet and Burke issue a strong warning in the current American Journal of Public Health about "the tobacco industry's attempt to discredit the scientific evidence on passive smoking, particularly the industry's use of the label 'junk science.' ... Unfortunately, 'junk science' has now become an ingrained pejorative. The public health community will need to be watchful in other arenas where the "junk science" gambit will be used. ... Trust Us We're Experts offer(s) a popular and cautionary account.... The lessons learned from this episode ...

"The pharmaceutical and biotechnological industries are funneling more and more cash into the pockets of academics who teach and study ethics," observes philosophy professor Carl Elliott, who works at a bioethics center. "Bioethicists have written for years about conflicts of interest in scientific research or patient care yet have paid little attention to the ones that might compromise bioethics itself," he notes, pointing to several cases in which companies like Eli Lilly have used funding to pressure ethicists into censoring or changing their views.

The American Medical Association is mounting a $1 million campaign to educate doctors about its ethics guidelines against accepting gifts from drug companies -- with most of the funding for the effort coming from drug companies.